Monitoring of nca-bt in blood samples of breast cancer patients

Details Monitoring of nca-bt in blood samples of breast cancer patients Monitoring of nca-bt in blood samples of breast cancer patients

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2082605

Monitoring the progression of breast cancer by performing a series of specific immunoassays over time to determine changes in the level of tumor marker NCA-BT in blood, e.g., serum, samples obtained from the patient. Increases in blood NCA-BT levels are indicative of a deteriorating condition whereas decreasing levels of blood NCA-BT indicate an improving condition.

Affiliated with

Also associated with

Rating

Monitoring of nca-bt in blood samples of breast cancer patients does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monitoring of nca-bt in blood samples of breast cancer patients, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monitoring of nca-bt in blood samples of breast cancer patients will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1804165